V Jayagopal

Summary

Affiliation: University of Hull
Country: UK

Publications

  1. ncbi The biological variation of insulin resistance in polycystic ovarian syndrome
    V Jayagopal
    Department of Medicine, University of Hull, United Kingdom
    J Clin Endocrinol Metab 87:1560-2. 2002
  2. ncbi Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes
    Vijay Jayagopal
    Department of Medicine, University of Hull, Hull, U K
    Diabetes Care 25:1709-14. 2002
  3. ncbi The biological variation of testosterone and sex hormone-binding globulin (SHBG) in polycystic ovarian syndrome: implications for SHBG as a surrogate marker of insulin resistance
    V Jayagopal
    Department of Medicine, University of Hull, United Kingdom HU3 2RW
    J Clin Endocrinol Metab 88:1528-33. 2003
  4. ncbi Orlistat is as beneficial as metformin in the treatment of polycystic ovarian syndrome
    V Jayagopal
    Department of Medicine, University of Hull, Michael White Centre for Diabetes and Endocrinology, Hull Royal Infirmary, Hull HU3 2RW, UK
    J Clin Endocrinol Metab 90:729-33. 2005
  5. ncbi Insulin resistance variability in women with anovulatory and ovulatory polycystic ovary syndrome, and normal controls
    L W Cho
    Department of Endocrinology and Diabetes, University of Hull, Hull, UK
    Horm Metab Res 43:141-5. 2011
  6. ncbi The mean and the biological variation of insulin resistance does not differ between polycystic ovary syndrome and type 2 diabetes
    Li Wei Cho
    Department of Medicine University of Hull, Hull Royal Infirmary, Hull, UK
    Ann Clin Biochem 46:218-21. 2009
  7. ncbi Biological variation of total testosterone, free androgen index and bioavailable testosterone in polycystic ovarian syndrome: implications for identifying hyperandrogenaemia
    L W Cho
    Department of Medicine, University of Hull, UK
    Clin Endocrinol (Oxf) 68:390-4. 2008
  8. ncbi Erythropoetin treatment significantly alters measured glycated haemoglobin (HbA1c)
    J M Ng
    Diabet Med 25:239-40. 2008

Collaborators

Detail Information

Publications8

  1. ncbi The biological variation of insulin resistance in polycystic ovarian syndrome
    V Jayagopal
    Department of Medicine, University of Hull, United Kingdom
    J Clin Endocrinol Metab 87:1560-2. 2002
    ..IR, measured using the homeostasis model assessment model, is significantly greater and more variable for overweight patients with PCOS. Therefore, this inherent variability needs to be accounted for in studies of IR in PCOS...
  2. ncbi Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes
    Vijay Jayagopal
    Department of Medicine, University of Hull, Hull, U K
    Diabetes Care 25:1709-14. 2002
    ..The aim of this study was to determine whether a dietary supplement with soy protein and isoflavones affected insulin resistance, glycemic control, and cardiovascular risk markers in postmenopausal women with type 2 diabetes...
  3. ncbi The biological variation of testosterone and sex hormone-binding globulin (SHBG) in polycystic ovarian syndrome: implications for SHBG as a surrogate marker of insulin resistance
    V Jayagopal
    Department of Medicine, University of Hull, United Kingdom HU3 2RW
    J Clin Endocrinol Metab 88:1528-33. 2003
    ..However, SHBG and testosterone concentrations measured in isolation are inherently unsuitable for use as tests to detect hyperandrogenemia...
  4. ncbi Orlistat is as beneficial as metformin in the treatment of polycystic ovarian syndrome
    V Jayagopal
    Department of Medicine, University of Hull, Michael White Centre for Diabetes and Endocrinology, Hull Royal Infirmary, Hull HU3 2RW, UK
    J Clin Endocrinol Metab 90:729-33. 2005
    ..The reduction in total testosterone was similar to that seen after treatment with metformin. Therefore, orlistat may prove to be a useful adjunct in the treatment of PCOS...
  5. ncbi Insulin resistance variability in women with anovulatory and ovulatory polycystic ovary syndrome, and normal controls
    L W Cho
    Department of Endocrinology and Diabetes, University of Hull, Hull, UK
    Horm Metab Res 43:141-5. 2011
    ..Since anovulatory PCOS therefore mimics the IR features of type 2 diabetes more closely, anovulation may be particularly associated with a higher cardiovascular risk compared to PCOS patients who ovulate...
  6. ncbi The mean and the biological variation of insulin resistance does not differ between polycystic ovary syndrome and type 2 diabetes
    Li Wei Cho
    Department of Medicine University of Hull, Hull Royal Infirmary, Hull, UK
    Ann Clin Biochem 46:218-21. 2009
    ..To test this hypothesis we compared the mean and biological variation in IR in PCOS to that of T2DM and to age- and weight-matched controls...
  7. ncbi Biological variation of total testosterone, free androgen index and bioavailable testosterone in polycystic ovarian syndrome: implications for identifying hyperandrogenaemia
    L W Cho
    Department of Medicine, University of Hull, UK
    Clin Endocrinol (Oxf) 68:390-4. 2008
    ..The aim of this study was to compare the biological variability of total testosterone with that of the biological variability of both the FAI and BioT, to determine the least variable measurement for clinical practice...
  8. ncbi Erythropoetin treatment significantly alters measured glycated haemoglobin (HbA1c)
    J M Ng
    Diabet Med 25:239-40. 2008